Paroxysmal dyskinesias in patients with HIV infection

Neurology

Volumn 52, Issue 1, 1999, Pages 109-114

  Mirsattari, S M ^a   Roke Berry, M E ^b   Holden, J K ^b   Ni, W ^e   Nath, A ^c   Power, C ^a,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; BENZATROPINE; BENZODIAZEPINE; CALBINDIN; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CLONAZEPAM; DIAZEPAM; DIDANOSINE; HALOPERIDOL; LORAZEPAM; OXAZEPAM; PHENOTHIAZINE; PHENYTOIN; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; ASTROCYTOSIS; ATHETOSIS; AUTOPSY; CHOREA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DYSARTHRIA; DYSKINESIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MYOCLONUS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SERODIAGNOSIS; SYNDROME;

EID: 0032953604     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.1.109     Document Type: Article

References (39)

1. Nath A, Jankovic J. Motor disorders in patients with human immunodeficiency virus infection. In: Rotterdam H, Sommers SC, Racz P, Meyer PR, eds. Progress in AIDS pathology. Vol. 1. New York: Field & Wood Medical Publishers, 1989:159-166.
2. Fahn S. The paroxysmal dyskinesias. In: Marsden CD, Fahn S, eds. Movement disorders 3. Oxford: Butterworth-Heinemann, 1994:310-345.
3. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38:571-579.
4. Nath A, Jankovic J, Pettigrew LC. Movement disorders and AIDS. Neurology 1987;37:37-41.
5. Power C, Kong P, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993;34: 339-350.
6. Masliah E, Ge N, Achim CL, Wiley CA. Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis. J Neuropathol Exp Neurol 1995;54:350-357.
7. Loong SC, Ong YY. Paroxysmal kinesigenic choreoathetosis: report of a case relieved by L-dopa. J Neurol Neurosurg Psychiatry 1973;31:921-924.
8. Perlmutter JS, Raichle ME. Pure hemidystonia with basal ganglia abnormalities on positron emission tomography. Ann Neurol 1984;15:228-233.
9. Fredow G, Loscher W. Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia. Eur J Pharmacol 1991; 192:207-219.
10. Nobrega JN, Richter A, Mcintyre Brunham W, Loscher W. Alterations in the brain GABA/benzodiazepine receptor-chloride ionophore complex in a genetic model of paroxysmal dystonia: a quantitative autoradiographic analysis. Neuroscience 1995;64:229-239.
11. Dunlop O, Bjorklund RA, Abdelnoor M, Myrvang B. Five different tests of reaction time evaluated in HIV seropositive men. Acta Neurol Scand 1992;86:260-266.
12. Karlsen NR, Reinvang I, Froland SS. Slowed reaction time in asymptomatic HIV-positive patients. Acta Neurol Scand 1992; 86:242-246.
13. Trenkwalder C, Straube A, Paulus W, et al. Postural imbalance: an early sign in HIV-1 infected patients. Eur Arch Psychiatry Clin Neurosci 1992;241:267-272.
14. Arnedt G, Hefter H, Elsing C, Strohmeyer G, Freund HJ. Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit. J Neurol 1990;237:362-368.
15. Kodama T, Numaguchi Y, Gellad FE, Sadato N. High signal intensity of both putamina in patients with HIV infection. Neuroradiology 1991;33:362-363.
16. Dal Pan GJ, McArthur JH, Aylward E, et al. Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 1992;42:2125-2130.
17. Chrysikopoulos HS, Press GA, Grafe MR, Hessenlink JR, Wiley CA. Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathological correlation. Radiology 1990;175:185-191.
18. Post MJD, Tate LG, Quencer RM, et al. CT, MR, and pathology in HIV encephalitis and meningitis. AJNR Am J Neuroradiol 1988;9:469-476.
19. Belman AL, Lantos G, Horoupian D, et al. AIDS: calcification of the basal ganglia in infants and children. Neurology 1986; 36:1192-1199.
20. Epstein LG, Sharer LR, Oleske JM, et al. Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 1986;78:678-687.
21. Wehn SM, Heinz ER, Burger PC, Boyko OB. Dilated Virchow-Robin spaces in cryptococcal meningitis associated with AIDS: CT and MR findings. J Comput Assist Tomogr 1989;13: 756-762.
22. Holman BL, Garada B, Johnson KA, et al. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J Nucl Med 1992;33:1312-1315.
23. Rottenberg DA, Moller JR, Strother SC, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987; 22:700-706.
24. Berger JR, Kumar M, Kumar A, et al. Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 1994;8:67-71.
25. Larsson M, Hagberg L, Norkrans G, Forsman A. Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection. J Neurosci Res 1989;23:441-446.
26. Larsson M, Hagberg L, Forsman A, Norkrans G. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. J Neurosci Res 1991;28:406-409.
27. Sofice E, Riederer P, Schmidt B, et al. Biogenic amines and metabolites in CSF from patients with HIV infection. Biogenic Amines 1992;8(5):293-298.
28. Kieburtz KD, Epstein LG, Gelbard HA, Greenamyre JT. Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Arch Neurol 1994;48:1281-1284.
29. Navia BA, Cho E, Petito C, Price RW. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986;19:525-535.
30. Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1991;82:39-44.
31. Cornford ME, Holden JK, Boyd MC, Berry K, Vinters HV. Neuropathology of the acquired immunodeficiency syndrome (AIDS): report of 39 autopsies from Vancouver, British Columbia. Can J Neurol Sci 1992;19:442-452.
32. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in sub-acute AIDS encephalitis. Acta Neuropathol 1990;80:393-400.
33. Power C, Moench T, Peeling J, Kong PA, Langelier T. Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain. Neuroscience 1997;77:1175-1185.
34. Luthert PJ, Mongomery MM, Dean AF, et al. Hippocampal neuronal atrophy in rhesus macaques following infection with simian immunodeficiency virus. Neuropathol Appl Neurobiol 1995;21:529-534.
35. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA. Selective vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 1992;51:585-593.
36. Baimbridge KG, Celio MR, Rogers JH. Calcium-binding proteins in the nervous system. Trends Neurosci 1992;15(8):303-308.
37. Nath A, Padua RA, Geiger JD. HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium. Brain Res 1995;678:200-206.
38. Wein T, Anderman F, Silver K, et al. Exquisite sensitivity of paroxysmal kinesigenic choreoathetosis to carbamazepine. Neurology 1986;47:1104-1106.
39. Cooper JR, Bloom FE, Roth R. The biochemical basis of neuropharmacology. 7th ed. New York: Oxford University Press, 1996:140.